Over the last 20 years, a large body of work in the literature has focused on the folded structures formed by peptide sequences containing backbone homologated residues. Currently increasing interest in peptide based vaccines for several infectious diseases, and non-infectious diseases. The work of Seebach in Zurich [1] and Gellman in Madison [2], established that oligomers of β amino acid residues can form novel helical structures in solution and in the solid state. Two distinct types of hydrogen bonded helical structures were demonstrated in these studies for oligomeric β peptides. The C12 helix which is an analog of the canonical 310 helical structure in “all α” sequences, has the same hydrogen bond directionality (C=Oi …..H-Ni+3). The second helical form, the C14 helix, has the opposite directionality (C=Oi…..H-Ni+4), which is unprecedented in α peptide sequences [3,4]. These reports sparked a flurry of activity on the conformational properties of β peptide oligomers. An early study from Appavu et al. [3-7], had demonstrated that unsubstituted β and γ amino acid residues can be incorporated into oligopeptide helices, without disturbing the overall helical fold [4].
Keywords: Oligomeric β peptides; β-amino acid residues; Gabapentin
Published on: Mar 14, 2016 Pages: 1-3
Full Text PDF
Full Text HTML
DOI: 10.17352/jvi.000012
CrossMark
Publons
Harvard Library HOLLIS
Search IT
Semantic Scholar
Get Citation
Base Search
Scilit
OAI-PMH
ResearchGate
Academic Microsoft
GrowKudos
Universite de Paris
UW Libraries
SJSU King Library
SJSU King Library
NUS Library
McGill
DET KGL BIBLiOTEK
JCU Discovery
Universidad De Lima
WorldCat
VU on WorldCat
PTZ: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."